Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis.
Zaitsev S, Spitzer D, Murciano JC, Ding BS, Tliba S, Kowalska MA, Bdeir K, Kuo A, Stepanova V, Atkinson JP, et al. J Pharmacol Exp Ther. 2010 Mar; 332(3):1022-31. Epub 2009 Dec 1.